Ex-Ante-Transparenzbekanntmachung § 130c Abs. 1 SGB V Tezspire 210 mg(R) Wirkstoff: Tezepelumab ATC-Code: R03DX11
Tender information
DE_BKMSMünchen, Germany
- Type
- goods
- Procedure
- Negotiated without prior call for competition
- Ref. number
- 17ea37b1-6648-4c07-b4f7-22022c5eeceb
- CPV
- 33600000
Arzneimittelrabattvertrag § 130c Abs. 1 SGB V Arzneimittelbezeichnung: Tezspire 210 mg(R) Wirkstoff: Tezepelumab ATC-Code: R03DX11